Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models

European Journal of Human Genetics

Volumn 19, Issue 2, 2011, Pages 180-185

  Moonesinghe, Ramal ^a   Khoury, Muin J ^b   Liu, Tiebin ^b   Janssens, A Cecile J W ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

additive models; discriminative accuracy; genomic profiles; sensitivity; specificity

Indexed keywords

ACCURACY; ARTICLE; CONTROLLED STUDY; EFFECT SIZE; GENE FREQUENCY; GENETIC PROCEDURES; GENETIC VARIABILITY; GENOMIC PROFILING; GENOMICS; GENOTYPE; HUMAN; MODEL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MODELS, GENETIC; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 78651398055     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.165     Document Type: Article

References (18)

1. Morris JK, Wald NJ: Graphical presentation of distributions of risk in screening. J Med Screen 2005; 12: 155-160.
2. Woolas RP, Conaway M, Xu F et al: Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses. Gynecol Oncol 1995; 59: 111-116.
3. Wald NJ, Morris JK, Rish S: The efficacy of combining several risk factors as a screening test. J Med Screen 2005; 12: 197-201.
4. Skates SJ, Horick N, Yu Y et al: Preoperative sensitivity and specificity for early stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol 2004; 22: 4059-4066.
5. Weedon MN, McCarthy MI, Hitman G et al: Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLOS Med 2006; 3: e374.
6. Podgoreanu MV, White WD, Morris RWet al: Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006; 114: I275-I281.
7. Vaxillaire M, Veslot J, Dina C et al: Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2008; 57: 244-254.
8. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic Susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-36.
9. Risch N: The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001; 10: 733-741.
10. Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000; 26: 411-414.
11. Hanley JA: Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 1989; 29: 307-335.
12. Pepe MS: Receiver operating characteristic methodology. J Am Stat Assoc 2000; 95: 308-311.
13. Khoury MJ, Newill CA, Chase GA: Epidemiologic evaluation of screening for risk factors: application to genetic screening. Am J Public Health 1985; 75: 1204-1208.
14. Moonesinghe R: A refinement to 'how many genes underlie the occurrence of common complex diseases in the population?'. Int J Epidemiol 2006; 35: 497.
15. Zheng SL, Sun J, Wiklund F et al: Cumulative association of five genetic variants with prostate cancer. N Eng J Med 2008; 358: 910-919.
16. Lund E: Comparison of additive and multiplicative models for reproductive risk factors and post-menopausal breast cancer. Stat Med 1995; 14: 267-274.
17. Gonzalez ABD, Cox DR: Additive and multiplicative models for the joint effect of two risk factors. Biostatistics 2005; 6: 1-9.
18. Wray NR, Goddard ME, Visscher PM: Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 2007; 17: 1520-1528.